Inmed Pharmaceuticals Inc Stock Price To Earning
| MWG0 Stock | 4.17 0.23 5.84% |
INMED PHARMACEUTICALS INC fundamentals help investors to digest information that contributes to INMED PHARMACEUTICALS's financial success or failures. It also enables traders to predict the movement of INMED Stock. The fundamental analysis module provides a way to measure INMED PHARMACEUTICALS's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to INMED PHARMACEUTICALS stock.
INMED |
INMED PHARMACEUTICALS INC Company Price To Earning Analysis
INMED PHARMACEUTICALS's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Based on the latest financial disclosure, INMED PHARMACEUTICALS INC has a Price To Earning of 0.0 times. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Price To Earning (which currently averages 0.0) industry. This indicator is about the same for all Germany stocks average (which is currently at 0.0).
Did you try this?
Run Commodity Channel Now
Commodity ChannelUse Commodity Channel Index to analyze current equity momentum |
| All Next | Launch Module |
About INMED PHARMACEUTICALS Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze INMED PHARMACEUTICALS INC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of INMED PHARMACEUTICALS using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of INMED PHARMACEUTICALS INC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in INMED Stock
INMED PHARMACEUTICALS financial ratios help investors to determine whether INMED Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in INMED with respect to the benefits of owning INMED PHARMACEUTICALS security.